Poly(2‐oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors

Abstract

Many current nanoformulations of taxanes are hampered by low drug‐loading capacity and unfavorable physicochemical characteristics such as large particles size (>100 nm) and/or low size uniformity. We have previously reported on taxane nanoformulations, based on poly(2‐oxazoline) polymeric micelles that display an extremely high taxane loading capacity (>40% w/w) and particle size below 50 nm. Previous work was based on a triblock copolymer having poly(2‐butyl‐2‐oxazoline) as the hydrophobic block and poly(2‐methyl‐2‐oxazoline) as the hydrophilic blocks. This paper explores the effects of various formulation parameters such as (i) the drug and polymer structure; (ii) the drug and polymer concentration; and (iii) the composition of aqueous medium on the solubilization behavior and physicochemical properties of the resulting formulations. In addition, in vitro anticancer activity is reported. Despite numerous variations of the hydrophobicity, polarity or addition of aromatic residues in the hydrophobic core, the triblock copolymer with the poly(2‐butyl‐2‐oxazoline) block remains the polymer with the highest drug‐loading capacity. Notably, the formulation was easily scalable with uncompromised encapsulation efficacy, loading capacity, and physicochemical properties. The taxane formulations were stable upon storage (water, saline, and dextrose solution) for 1–2 weeks and could be lyophilized and re‐dispersed without compromising the formulation properties. Furthermore, the micelles remained stable upon dilution. The drug‐loaded poly(2‐oxazoline) micelles showed high toxicity against several cancer cell lines. Taken together, these results underscore the potential of poly(2‐oxazoline) micelles as formulation excipient for taxanes and possibly other hydrophobic drugs. Copyright © 2015 John Wiley & Sons, Ltd.